AR229035A1 - Metodo para la preparacion de un derivado 2-n-metilol de cefalexina - Google Patents

Metodo para la preparacion de un derivado 2-n-metilol de cefalexina

Info

Publication number
AR229035A1
AR229035A1 AR287074A AR28707481A AR229035A1 AR 229035 A1 AR229035 A1 AR 229035A1 AR 287074 A AR287074 A AR 287074A AR 28707481 A AR28707481 A AR 28707481A AR 229035 A1 AR229035 A1 AR 229035A1
Authority
AR
Argentina
Prior art keywords
cephalexine
preparation
methylol derivative
methylol
derivative
Prior art date
Application number
AR287074A
Other languages
English (en)
Spanish (es)
Original Assignee
Neopharmed Spa
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharmed Spa, Crinos Industria Farmaco filed Critical Neopharmed Spa
Application granted granted Critical
Publication of AR229035A1 publication Critical patent/AR229035A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AR287074A 1980-10-13 1981-10-13 Metodo para la preparacion de un derivado 2-n-metilol de cefalexina AR229035A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT25267/80A IT1195762B (it) 1980-10-13 1980-10-13 Derivati idrosolubili della cefalexina e procedimento per la loro produzione

Publications (1)

Publication Number Publication Date
AR229035A1 true AR229035A1 (es) 1983-05-31

Family

ID=11216176

Family Applications (1)

Application Number Title Priority Date Filing Date
AR287074A AR229035A1 (es) 1980-10-13 1981-10-13 Metodo para la preparacion de un derivado 2-n-metilol de cefalexina

Country Status (17)

Country Link
US (1) US4471115A (fr)
EP (1) EP0049928B1 (fr)
JP (1) JPS5767583A (fr)
KR (1) KR880000691B1 (fr)
AR (1) AR229035A1 (fr)
AT (1) ATE35813T1 (fr)
AU (1) AU548333B2 (fr)
BE (1) BE890718A (fr)
CA (1) CA1181741A (fr)
DE (1) DE3176811D1 (fr)
DK (1) DK451281A (fr)
ES (1) ES506213A0 (fr)
FR (1) FR2491927B1 (fr)
IT (1) IT1195762B (fr)
NO (1) NO813433L (fr)
PT (1) PT73807B (fr)
YU (1) YU246381A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3759070A4 (fr) * 2018-02-28 2021-12-08 Bridge Biotherapeutics, Inc. Sels hydrosolubles de peptides lipidés et leurs procédés de préparation et d'utilisation
KR20200138326A (ko) * 2018-03-29 2020-12-09 에스.아이.에스. 슐로브 이노베이티브 사이언스 리미티드 염증성 시토카인을 억제하기 위한 약제학적 조성물
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1265315A (fr) * 1968-04-05 1972-03-01 Glaxo Lab Ltd
BE786924A (fr) * 1971-07-28 1973-01-29 Squibb & Sons Inc Antibiotiques, leur preparation et leurs utilisations therapeutiques
US3796709A (en) * 1971-11-19 1974-03-12 Squibb & Sons Inc (alpha-cyanamino)acetamidocephalosporins
BE792229A (fr) * 1971-12-03 1973-06-01 Bristol Myers Co Agents antibacteriens heterocycliques azotes et procede pour les preparer
US3880842A (en) * 1972-05-30 1975-04-29 Squibb & Sons Inc Cephalosporin derivatives
US3988326A (en) * 1974-02-22 1976-10-26 Meiji Seika Kaisha, Ltd. Process for N-acylation of 7 amino cephem compounds

Also Published As

Publication number Publication date
PT73807A (fr) 1981-11-01
CA1181741A (fr) 1985-01-29
YU246381A (en) 1983-10-31
BE890718A (fr) 1982-02-01
FR2491927B1 (fr) 1985-07-12
IT1195762B (it) 1988-10-27
NO813433L (no) 1982-04-14
ATE35813T1 (de) 1988-08-15
IT8025267A0 (it) 1980-10-13
AU7624781A (en) 1982-04-22
EP0049928B1 (fr) 1988-07-20
KR830007681A (ko) 1983-11-04
DK451281A (da) 1982-04-14
PT73807B (fr) 1983-01-17
AU548333B2 (en) 1985-12-05
EP0049928A3 (en) 1983-04-06
KR880000691B1 (ko) 1988-04-23
FR2491927A1 (fr) 1982-04-16
JPS5767583A (en) 1982-04-24
ES8206533A1 (es) 1982-08-16
ES506213A0 (es) 1982-08-16
EP0049928A2 (fr) 1982-04-21
DE3176811D1 (en) 1988-08-25
US4471115A (en) 1984-09-11

Similar Documents

Publication Publication Date Title
ES505517A0 (es) Un procedimiento para la preparacion de un derivado de n- arilbenzamida
ES505950A0 (es) Un procedimiento para la preparacion de un derivado de tia- zol
ES509658A0 (es) Un procedimiento para la produccion de un derivado de carbostirilo
ES504103A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES502906A0 (es) Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
ES505678A0 (es) Un procedimiento para la preparacion de un derivado de 3- aril-5-isotiazol
ES502994A0 (es) Un procedimiento para la preparacion de derivados de pirazo-lopiridacina
ES502792A0 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES499559A0 (es) Un procedimiento para la preparacion de derivados de pirrol
ES536982A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo
ES504764A0 (es) Un procedimiento para la preparacion de un derivado 2-tiope-nem
ES501572A0 (es) Un metodo para la preparacion de glucosidos de antraciclina
ES507755A0 (es) Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida.
ES504927A0 (es) Un proceso para la preparacion de derivados de n-alquilimi- dazoles sustituidos
ES504376A0 (es) Un procedimiento para la preparacion de un derivado de fene-tilamina
ES521361A0 (es) Un metodo para preparar un derivado 14-acilico de lankacidina.
ES492230A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbostirilo
ES507975A0 (es) Un metodo para preparar derivados de pirazolina.
ES500911A0 (es) Un procedimiento para la preparacion de derivados de ergoli-na
ES501232A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES520909A0 (es) Un metodo para la preparacion de un derivado de tilosina.
AR229035A1 (es) Metodo para la preparacion de un derivado 2-n-metilol de cefalexina
ES501534A0 (es) Un procedimiento para la preparacion de derivado de bis-hidroxibencilo.
ES498145A0 (es) Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas
ES528633A0 (es) Un metodo para la preparacion de nuevos derivados de fenilbutilaldehido